Historical record - last NADAC effective date: 4/19/2023
Product Information
OXYMORPHONE HCL 5 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.5201 per EA under NDC 00054028325. Its NADAC has been published 542 times since Nov 28, 2013.
FDA first approved this application on Sep 27, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054028325
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/19/2023
Active Ingredients
OXYMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090964FDA Approved
9/27/2010
TE Code
AB
On Market Since
9/27/2010
Pharmacological Classes
Price Statistics
The NADAC for OXYMORPHONE HCL 5 MG TABLET has been published 542 times since Nov 28, 2013, and over the history we have for it it has declined 74.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5201 per EA |
|---|---|
| All-time high | $2.1959 (Jan 15, 2014) |
| All-time low | $0.3420 (Sep 23, 2020) |
| Median price | $0.9216 |
| Average price | $1.0244 |
| Largest weekly change | +123.9% (Dec 23, 2020) |
| Weeks tracked | 542 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
0.0%
5Y
+38.3%
All
-74.6%
Last surveyed Apr 10, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the oxymorphone hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYMORPHONE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYMORPHONE HCL 5 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.5201 per EA (NDC 00054028325), effective Apr 10, 2024.
How has the price of OXYMORPHONE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYMORPHONE HCL 5 MG TABLET has declined 74.6%. It has been tracked across 542 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OXYMORPHONE HCL 5 MG TABLET?
Since Nov 28, 2013, the NADAC for OXYMORPHONE HCL 5 MG TABLET has ranged from a low of $0.3420 (Sep 23, 2020) to a high of $2.1959 (Jan 15, 2014), with a median of $0.9216 per EA.
Are there cheaper alternatives to OXYMORPHONE HCL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of OXYMORPHONE HCL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OXYMORPHONE HCL 5 MG TABLET?
OXYMORPHONE HCL 5 MG TABLET (NDC 00054028325) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.